Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

RADIOFREQUENCY ABLATION OF HEPATOCELLUAR CARCINOMA IS SAFE AND EFFECTIVE IN CONTROLLING TUMOR GROWTH IN WAIT LISTED LIVER TRANSPLANT CANDIDATES.

RADIOFREQUENCY ABLATION OF HEPATOCELLUAR CARCINOMA IS SAFE AND EFFECTIVE IN CONTROLLING TUMOR GROWTH IN WAIT LISTED LIVER TRANSPLANT CANDIDATES. . World Transplant Congress 2006, Boston, MA. Transplant Proceedings. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.